These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28706775)

  • 1. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?
    Hagström H
    Curr Hepatol Rep; 2017; 16(2):152-157. PubMed ID: 28706775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
    Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall HU; Hultcrantz R; Stål P
    Scand J Gastroenterol; 2017 Feb; 52(2):159-165. PubMed ID: 27650916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.
    Mitchell T; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Ching H; Hamdorf J; Adams LA
    Am J Gastroenterol; 2018 Oct; 113(10):1484-1493. PubMed ID: 29899440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alcohol consumption on nonalcoholic fatty liver disease.
    Weng G; Dunn W
    Transl Gastroenterol Hepatol; 2019; 4():70. PubMed ID: 31620652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol, smoking and the liver disease patient.
    Hagström H
    Best Pract Res Clin Gastroenterol; 2017 Oct; 31(5):537-543. PubMed ID: 29195673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
    Ajmera VH; Terrault NA; Harrison SA
    Hepatology; 2017 Jun; 65(6):2090-2099. PubMed ID: 28100008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents.
    Ayonrinde OT; Oddy WH; Adams LA; Mori TA; Beilin LJ; de Klerk N; Olynyk JK
    J Hepatol; 2017 Sep; 67(3):568-576. PubMed ID: 28619255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.
    Chang Y; Cho YK; Kim Y; Sung E; Ahn J; Jung HS; Yun KE; Shin H; Ryu S
    Hepatology; 2019 Jan; 69(1):64-75. PubMed ID: 30019340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.
    Sánchez-Jiménez BA; Brizuela-Alcántara D; Ramos-Ostos MH; Alva-López LF; Uribe-Esquivel M; Chávez-Tapia NC
    Alcohol; 2018 Jun; 69():63-67. PubMed ID: 29660603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities.
    Idalsoaga F; Kulkarni AV; Mousa OY; Arrese M; Arab JP
    Front Med (Lausanne); 2020; 7():448. PubMed ID: 32974366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection.
    Westin J; Lagging LM; Spak F; Aires N; Svensson E; Lindh M; Dhillon AP; Norkrans G; Wejstål R
    J Viral Hepat; 2002 May; 9(3):235-41. PubMed ID: 12010513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of alcohol consumption with liver histological features in non-cirrhotic patients.
    Kondili LA; Taliani G; Cerga G; Tosti ME; Babameto A; Resuli B
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):155-9. PubMed ID: 15674092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.
    Kwon HK; Greenson JK; Conjeevaram HS
    Liver Int; 2014 Jan; 34(1):129-35. PubMed ID: 23809459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D; Coates PM
    Alcohol; 2004 Aug; 34(1):3-8. PubMed ID: 15670659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD).
    Seitz HK; Mueller S; Hellerbrand C; Liangpunsakul S
    Hepatobiliary Surg Nutr; 2015 Jun; 4(3):147-51. PubMed ID: 26151054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.
    Teli MR; Day CP; Burt AD; Bennett MK; James OF
    Lancet; 1995 Oct; 346(8981):987-90. PubMed ID: 7475591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2001; (3):CD002148. PubMed ID: 11687017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.
    Kwon I; Jun DW; Moon JH
    Gut Liver; 2019 May; 13(3):308-314. PubMed ID: 30400736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.